Advair 250 · DIN 02245127 · 25/250 mcg/Metered Dose · inhaler, 120 doses
Limited Use, Reason for Use code 330 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 330 required
Write on scriptReason for Use code 330 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 330
Reason for Use code 330
For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms.
Coverage limit:
LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Advair 250 · DIN 02245127
Manufacturer: GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care; listing date 2003-01-30
Health Canada: Marketed since 2001-12-21 · brand ADVAIR · ATC R03AK06 SALMETEROL AND FLUTICASONE · form Aerosol (metered-dose) · route Inhalation · ingredients SALMETEROL (SALMETEROL XINAFOATE) 25 MCG/ACT, FLUTICASONE PROPIONATE 250 MCG/ACT · company Glaxosmithkline inc · schedule Prescription
Advair 250: Formulary list price $196.54 per unit (the source does not state the unit; exact figure $196.5400). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245127)
Source record
DIN 02245127: Advair 250
Raw flags: sec12=Y, sec3=Y
Item: 121200086; group id 237; item number 0420; lccId 00044; manufacturer id GSK
Source form: Inh-120 Dose Pk; strength: 25/250mcg/Metered Dose
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $196.5400; ministry $196.5400
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245127
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=69137
Shortage status: not checked (no credentials)